Skip to content
akaturk Academic measurement
Sign in Register

Academician

EMRAH OKUR

DOKTOR ÖĞRETİM ÜYESİ

KÜTAHYA DUMLUPINAR ÜNİVERSİTESİ FEN-EDEBİYAT FAKÜLTESİ BİYOLOJİ BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Biyoloji

A quick look at recorded outputs — details below.

  • Articles 10
  • Projects 0
  • Books 1
  • Proceedings 9
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 4 Q2 2 Q3 4 Q4 0
WoS (JCR) Q1 2 Q2 2 Q3 3 Q4 3
TR Index 0 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 0
Avg percentile 65.1%
Top 1% share 0.0%
Top 10% share 0.0%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

10 publications total

Scopus (SJR)
Q1 4 Q2 2 Q3 4 Q4 0
WoS (JCR)
Q1 2 Q2 2 Q3 3 Q4 3
TR Index
0 articles

Article list

  1. 2023 Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa MEDICAL ONCOLOGY DOI 10.1007/s12032-023-02173-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex 49.5%
  2. 2020 An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line CYTOTECHNOLOGY DOI 10.1007/s10616-019-00362-x YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.7%
  3. 2019 A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis CELL BIOLOGY AND TOXICOLOGY DOI 10.1007/s10565-018-9435-z YÖKSİS SJR Q1 JCR Q1 OpenAlex 64.3%
  4. 2017 Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line Cytotechnology DOI 10.1007/s10616-017-0079-2 YÖKSİS SJR Q2 JCR Q3 OpenAlex 83.4%
  5. 2016 Effects of p38 MAP kinase inhibitors on MDAMB 231 cell line The FEBS Journal DOI 10.1111/febs.13808 YÖKSİS SJR Q1 JCR Q2 OpenAlex 11.3%
  6. 2016 A novel combination treatment for breast cancer cells involving BAPTA AM and proteasome inhibitor bortezomib Oncology Letters DOI 10.3892/ol.2016.4597 YÖKSİS SJR Q3 JCR Q4 OpenAlex 74.5%
  7. 2015 A proteomic analysis of p53 independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line Journal of Proteomics DOI 10.1016/j.jprot.2014.09.010 YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.6%
  8. 2014 Data for a proteomic analysis of p53 independent induction of apoptosis by bortezomib Data in Brief DOI 10.1016/j.dib.2014.09.003 YÖKSİS SJR Q3 JCR Q3
  9. 2012 The p53 independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib Tumor Biology DOI 10.1007/s13277-012-0386-3 YÖKSİS SJR Q1 JCR Q3 OpenAlex 86.5%
  10. 2010 Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line Molecular Medicine Reports DOI 10.3892/mmr_00000262 YÖKSİS SJR Q3 JCR Q4 OpenAlex 75.6%

Back to academicians